I have followed pharma market for 7 years. Unless we beleive they can pull off 40% earnings growth look for this one to pull back to acceptable levels. I agree with your $50 per share and bet we can do that in may or june 1998
The sale of valleylab for $425 million is the first of what i believe will be a total divestiture of non performing Medical device companies. howmedica, AMS, Schneider account for almost a billion dollars of sales but very little revenue. Pfizer i believe will concentrate on their strenghths and unload all these companies that were acquired in the early 80's. Do not overlook the value of the monies in the pension plans, huge amounts due to their holdings of these stocks. the very real potential of a split, if history is any judge, plus the merger mania of Drug companies in their need to pool R&D. $100 a share, has to happen. profits from these company sales will reflect in p&e ratioes.